AAAAAA
Results: 1-25/35
Authors:
LEFF P
SCARAMELLINI C
Citation: P. Leff et C. Scaramellini, PROMISCUITY, PRE-COUPLING AND INSTABILITY, Trends in pharmacological sciences, 19(1), 1998, pp. 13-13
Authors:
BERG KA
MAAYANI S
GOLDFARB J
SCARAMELLINI C
LEFF P
CLARKE WP
Citation: Ka. Berg et al., EFFECTOR PATHWAY-DEPENDENT RELATIVE EFFICACY AT SEROTONIN TYPE 2A AND2C RECEPTORS - EVIDENCE FOR AGONIST-DIRECTED TRAFFICKING OF RECEPTOR STIMULUS, Molecular pharmacology, 54(1), 1998, pp. 94-104
Authors:
JARVIS GE
HUMPHRIES RG
ROBERTSON MJ
LEFF P
Citation: Ge. Jarvis et al., ADP CAN INDUCE AGGREGATION OF HUMAN PLATELETS VIA BOTH P2Y(IOTA) AND P-2-TAU RECEPTORS, British Journal of Pharmacology, 124, 1998, pp. 32-32
Authors:
FAGURA MS
DAINTY IA
MCKAY GD
KIRK IP
HUMPHRIES RG
ROBERTSON MJ
DOUGALL IG
LEFF P
Citation: Ms. Fagura et al., P2Y(1)-RECEPTORS IN HUMAN PLATELETS WHICH ARE PHARMACOLOGICALLY DISTINCT FROM P2Y(ADP)-RECEPTORS, British Journal of Pharmacology, 124(1), 1998, pp. 157-164
Authors:
LEFF P
SCARAMELLINI C
LAW C
MCKECHNIE K
Citation: P. Leff et al., A 3-STATE RECEPTOR MODEL OF AGONIST ACTION, Trends in pharmacological sciences, 18(10), 1997, pp. 355-362
Authors:
SCARAMELLINI C
BENNETT G
LEFF P
Citation: C. Scaramellini et al., ANALYSIS OF AGONIST-AGONIST INTERACTIONS - THE CRUCIAL INFLUENCE OF CURVE SHAPE, Journal of pharmacological and toxicological methods, 37(3), 1997, pp. 167-178
Authors:
LYDFORD SJ
MCKECHNIE KCW
LEFF P
Citation: Sj. Lydford et al., INTERACTION OF BW-A868C, A PROSTANOID DP-RECEPTOR ANTAGONIST, WITH 2 RECEPTOR SUBTYPES IN THE RABBIT ISOLATED SAPHENOUS-VEIN (VOL 52, PG 125, 1996), Prostaglandins, 53(1), 1997, pp. 59-62
Authors:
TOMLINSON W
HUMPHRIES RG
ROBERTSON MJ
LEFF P
Citation: W. Tomlinson et al., ARL-67085 AND ARL-66096 ARE SLOWLY DISSOCIATING COMPETITIVE P-2T-PURINOCEPTOR ANTAGONISTS, British Journal of Pharmacology, 120, 1997, pp. 131-131
Authors:
DAINTY IA
DOUGALL IG
MCKAY GD
LEFF P
Citation: Ia. Dainty et al., PHARMACOLOGICAL CHARACTERIZATION OF A CLONED BOVINE P2Y(1)-PURINOCEPTOR TRANSFECTED INTO JURKAT CELLS, British Journal of Pharmacology, 120, 1997, pp. 299-299
Authors:
LYDFORD SJ
MCKECHNIE KCW
LEFF P
Citation: Sj. Lydford et al., INTERACTION OF BW-A868C, A PROSTANOID DP-RECEPTOR ANTAGONIST, WITH 2 RECEPTOR SUBTYPES IN THE RABBIT ISOLATED SAPHENOUS-VEIN, Prostaglandins, 52(2), 1996, pp. 125-139
Authors:
LIU YJ
JACKSON DM
BLACKHAM A
LEFF P
Citation: Yj. Liu et al., PARTIAL AGONIST EFFECTS OF BW A868C, A SELECTIVE DP RECEPTOR ANTAGONIST, ON CL- SECRETION IN DOG TRACHEAL EPITHELIUM, European journal of pharmacology, 304(1-3), 1996, pp. 117-122
Authors:
LEFF P
Citation: P. Leff, INVERSE AGONISM - THEORY AND PRACTICE, Trends in pharmacological sciences, 16(8), 1995, pp. 256-256
Authors:
HUMPHRIES RG
ROBERTSON MJ
LEFF P
Citation: Rg. Humphries et al., A NOVEL SERIES OF P-2T PURINOCEPTOR ANTAGONISTS - DEFINITION OF THE ROLE OF ADP IN ARTERIAL THROMBOSIS, Trends in pharmacological sciences, 16(6), 1995, pp. 179-181
Authors:
KENNEDY C
LEFF P
Citation: C. Kennedy et P. Leff, HOW SHOULD P-2X PURINOCEPTORS BE CLASSIFIED PHARMACOLOGICALLY, Trends in pharmacological sciences, 16(5), 1995, pp. 168-174
Authors:
LEFF P
Citation: P. Leff, THE 2-STATE MODEL OF RECEPTOR ACTIVATION, Trends in pharmacological sciences, 16(3), 1995, pp. 89-97
Authors:
JENKINSON DH
BARNARD EA
HOYER D
HUMPHREY PPA
LEFF P
SHANKLEY NP
Citation: Dh. Jenkinson et al., INTERNATIONAL UNION OF PHARMACOLOGY COMMITTEE ON RECEPTOR NOMENCLATURE AND DRUG CLASSIFICATION .9. RECOMMENDATIONS ON TERMS AND SYMBOLS IN QUANTITATIVE PHARMACOLOGY, Pharmacological reviews, 47(2), 1995, pp. 255-266
Authors:
KENNEDY C
LEFF P
Citation: C. Kennedy et P. Leff, PHARMACOLOGY - PAINFUL CONNECTION FOR ATP, Nature, 377(6548), 1995, pp. 385-386
Authors:
BOND RA
LEFF P
JOHNSON TD
MILANO CA
ROCKMAN HA
MCMINN TR
APPARSUNDARAM S
HYEK MF
KENAKIN TP
ALLEN LF
LEFKOWITZ RJ
Citation: Ra. Bond et al., PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR, Nature, 374(6519), 1995, pp. 272-276
Authors:
HUMPHRIES RG
TOMLINSON W
CLEGG JA
INGALL AH
KINDON ND
LEFF P
Citation: Rg. Humphries et al., PHARMACOLOGICAL PROFILE OF THE NOVEL P-2T-PURINOCEPTOR ANTAGONIST, FPL-67085 IN-VITRO AND IN THE ANESTHETIZED RAT IN-VIVO, British Journal of Pharmacology, 115(6), 1995, pp. 1110-1116
Authors:
LI SW
MCKECHNIE K
GRIFFITHS RJ
BOUGHTONSMITH NK
BLACKHAM A
LEFF P
Citation: Sw. Li et al., PROSTANOID ANTAGONIST AH-6809 ANTAGONIZES PGE2 INHIBITION OF HUMAN NEUTROPHIL ACTIVATION, British Journal of Pharmacology, 114, 1995, pp. 82-82
Authors:
MCKECHNIE KCW
CRACK BE
DAINTY IA
LEFF P
Citation: Kcw. Mckechnie et al., THE EFFECT OF ECTO-ATPASE INHIBITION ON AGONIST POTENCY ORDERS AT P(2Y) AND P(2X) PURINOCEPTORS, British Journal of Pharmacology, 114, 1995, pp. 104-104
Authors:
SNEDDON P
WALKER H
LEFF P
KENNEDY C
Citation: P. Sneddon et al., ENHANCEMENT OF SYMPATHETIC, PURINERGIC NEUROTRANSMISSION BY A NOVEL ECTO-ATPASE INHIBITOR IN GUINEA-PIG ISOLATED VAS-DEFERENS, British Journal of Pharmacology, 114, 1995, pp. 109-109
Authors:
CRACK BE
POLLARD CE
BEUKERS MW
ROBERTS SM
HUNT SF
INGALL AH
MCKECHNIE KCW
IJZERMAN TP
LEFF P
Citation: Be. Crack et al., PHARMACOLOGICAL-ANALYSIS AND BIOCHEMICAL-ANALYSIS OF FPL-67156, A NOVEL, SELECTIVE INHIBITOR OF ECTO-ATPASE, British Journal of Pharmacology, 114(2), 1995, pp. 475-481
Authors:
LEFF P
Citation: P. Leff, THEORETICAL TREATMENT OF ONE-AGONIST-2-RECEPTOR SYSTEMS, Trends in pharmacological sciences, 15(9), 1994, pp. 320-321
Authors:
ROBERTSON MJ
DOUGALL IG
HARPER D
MCKECHNIE KCW
LEFF P
Citation: Mj. Robertson et al., AGONIST-ANTAGONIST INTERACTIONS AT ANGIOTENSIN RECEPTORS - APPLICATION OF A 2-STATE RECEPTOR MODEL, Trends in pharmacological sciences, 15(10), 1994, pp. 364-369